enow.com Web Search

  1. Ads

    related to: clinical trials in bladder cancer care

Search results

  1. Results from the WOW.Com Content Network
  2. Pfizer's bladder cancer therapy meets main goal in late-stage ...

    www.aol.com/news/pfizers-bladder-cancer-therapy...

    The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...

  3. Erdafitinib - Wikipedia

    en.wikipedia.org/wiki/Erdafitinib

    The efficacy of erdafitinib was studied in a clinical trial (NCT02365597) that included 87 adults with locally advanced or metastatic bladder cancer, with FGFR3 or FGFR2 genetic alterations, that had progressed following treatment with chemotherapy.

  4. Nadofaragene firadenovec - Wikipedia

    en.wikipedia.org/wiki/Nadofaragene_firadenovec

    The safety and effectiveness of nadofaragene firadenovec was evaluated in a multicenter clinical study (Study CS-003 (NCT02773849)) that included 157 participants with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer, 98 of whom had BCG-unresponsive carcinoma in situ with or without papillary tumors and could be evaluated for response.

  5. AOH1996 - Wikipedia

    en.wikipedia.org/wiki/AOH1996

    AOH1996 is an experimental anticancer medication which acts as a small molecule inhibitor of proliferating cell nuclear antigen (PCNA) and is in Phase I clinical trials at City of Hope as of August 2023 for the treatment of solid tumors. [1] [2] [3] [4]

  6. FDA approves bladder cancer treatment by Culver City company

    www.aol.com/news/fda-approves-bladder-cancer...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Neuvenge - Wikipedia

    en.wikipedia.org/wiki/Neuvenge

    Neuvenge is still in preliminary clinical trials and is evolving as of 2011. First Neuvenge trials were performed on patients with metastatic breast, ovarian or colorectal cancer that expressed HER-2 (HER2/neu). Some patients with stable disease after week 48 received an additional "booster" treatment using the identical protocol.

  8. Thomas Hutson - Wikipedia

    en.wikipedia.org/wiki/Thomas_Hutson

    [3] [4] As an expert in his field, [5] [6] he has served as the principal investigator on several international clinical trials on novel therapies in renal cell carcinoma, bladder cancer, and prostate cancer. [7] [8] In addition, he has authored over 500 scholarly academic and research papers. [9]

  9. Sarah Cannon Research Institute - Wikipedia

    en.wikipedia.org/wiki/Sarah_Cannon_Research...

    Sarah Cannon Research Institute (SCRI) is a research organization focusing on therapies for patients which include drugs that are in development. With corporate headquarters in Nashville, Tennessee , United States, it conducts community-based clinical trials in oncology , cardiology , gastroenterology , and other therapeutic areas. [ 1 ]

  1. Ads

    related to: clinical trials in bladder cancer care